SEC Filings

Filing date Description Form Filing Group View
A preliminary proxy statement providing notification matters to be brought to a vote PRE 14A
Proxy Filings
View HTML
Tender offer schedule and amendment filed by the issuer. SC TO-I
Other
XML - XBRL INSTANCE DOCUMENT View HTML
Report of unscheduled material events or corporate event 8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Amendment to a previously filed 8-K 8-K/A
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Report of unscheduled material events or corporate event 8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Amendment to a previously filed 8-K 8-K/A
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Report of unscheduled material events or corporate event 8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
25-NSE 25-NSE
Other
View HTML
Official notification to shareholders of matters to be brought to a vote ("Proxy") DEF 14A
Proxy Filings
View HTML
Report of unscheduled material events or corporate event 8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.